← Evidence map

ArticleTranslational lung cancer research2022

Neoadjuvant chemo-immunotherapy for lung cancer: how much is too much?

Nathaniel Deboever et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36636418